Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Norway (1)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Representativeness of stakeholders
Clinical study phase III